Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real-world registry study in Japan

Affiliations

• ¹ Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
• ² Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
• ³ Department of Hematology, Kanazawa University, Kanazawa, Japan.
• ⁴ Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
• ⁵ Department of Hematology, Toranomon Hospital, Tokyo, Japan.
• ⁶ Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
• ⁷ Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
• ⁸ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
• ⁹ Department of Hematology/Oncology and Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan.
• ¹⁰ Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
• ¹¹ Department of Hematology, National Hospital Organisation Kumamoto Medical Center, Kumamoto, Japan.
• ¹² Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
• ¹³ Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
• ¹⁴ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
• ¹⁵ Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
• ¹⁶ Hematopoietic Stem Cell Transplantation Division, National Cancer Hospital, Tokyo, Japan.
• ¹⁷ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
• ¹⁸ Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.